Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa

R. M. Sugg, N. R. Gonzales, D. E. Matherne, M. Ribo, Hashem Shaltoni, S. Baraniuk, E. A. Noser, J. C. Grotta

Research output: Contribution to journalArticle

29 Scopus citations

Abstract

We report myocardial injury in 20 recombinant factor VIIa (rFVIIa) treated and 110 nontreated patients with intracerebral hemorrhage. Patients were treated or received standard medical management. All received EKG and cardiac enzyme testing. Elevated troponin occurred in 20% treated vs 3% nontreated (p = 0.02). Myocardial infarction occurred in 10% vs 1% (p = 0.01). We found a significant increase in myocardial injury in rFVIIa treated patients.

Original languageEnglish (US)
Pages (from-to)1053-1055
Number of pages3
JournalNeurology
Volume67
Issue number6
DOIs
StatePublished - Sep 1 2006
Externally publishedYes

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa'. Together they form a unique fingerprint.

  • Cite this

    Sugg, R. M., Gonzales, N. R., Matherne, D. E., Ribo, M., Shaltoni, H., Baraniuk, S., Noser, E. A., & Grotta, J. C. (2006). Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa. Neurology, 67(6), 1053-1055. https://doi.org/10.1212/01.wnl.0000239154.51331.c4